Inflammation News and Research

RSS

Combination therapy of salmeterol and fluticasone improves survival in patients with COPD

A combination of two common medications may help patients with chronic obstructive pulmonary disease (COPD) live longer.

23 Oct 2006

FDA approves Omnaris, new hay fever drug

The U.S. Food and Drug Administration (FDA) has announced the approval of Omnaris (ciclesonide) nasal spray, a new drug for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis, commonly known as hay fever, in adults and children 12 years of age and older.

23 Oct 2006

$74 million allocated to study environmental causes of disease

As part of the new Exposure Biology Program, the National Institute of Environmental Health Sciences, a component of the National Institutes of Health, today announced $74 million in grant opportunities for the development of new technologies that will improve the measurement of environmental exposures that contribute to human disease.

19 Oct 2006

New treatment option gives hope to victims of head and neck cancers

More than 640,000 people worldwide are diagnosed with head and neck cancer each year, and more than 350,000 die from the disease annually.

19 Oct 2006

FDA approves Taxotere for head and neck cancers

The Food and Drug Administration (FDA) today approved Taxotere (docetaxel) Injection Concentrate for use in combination with cisplatin and fluorouracil prior to radiotherapy for the treatment of patients with inoperable, locally advanced squamous cell carcinoma of the head and neck (SCCHN).

18 Oct 2006

Underlying causes, frequencies, and outcomes of dilated cardiomyopathy

The mystery behind a commonly untreatable and undetected heart muscle disease in children is partially revealed for the first time in today's edition of the scientific journal JAMA.

17 Oct 2006

Researchers step toward therapy for respiratory syncytial virus

When a child under the age of 2 contracts a respiratory tract infection requiring hospitalization, odds are that the cause is respiratory syncytial virus (RSV).

17 Oct 2006

Tuberculosis fourfold the risk for Celiac sufferers

Swedish researchers are suggesting that people with celiac disease, also known as gluten intolerance, have an increased risk of developing tuberculosis (TB).

17 Oct 2006

Transport mechanism of bioactive molecule, S1P, identified

Virginia Commonwealth University researchers have identified how a bioactive molecule involved with allergy, inflammation and cancer is transported out of mast cells, according to findings published online this week in the Proceedings of the National Academy of Sciences.

17 Oct 2006

Topical treatment for psoriasis, eliminates need for injections

Apollo Life Sciences, a Sydney-based biotechnology company, has announced that its topical psoriasis treatment has outperformed current market-leading drugs in preclinical studies.

17 Oct 2006

Heme oxygenase-1 protects against lung damage in silicosis

Levels of heme oxygenase-1 (HO-1), an antioxidant that protects against reactive oxygen species (damaging oxygen molecules that cause direct tissue injury), become elevated in the lungs of chronic silicosis patients and could represent a new treatment approach for the disease.

16 Oct 2006

Walnuts better for the heart than olive oil

According to Spanish researchers walnuts might be even better for the arteries than olive oil.

10 Oct 2006

NIH funds study that may prevent cognitive dysfunctions among HIV-positive people

NIH is funding a recent effort aimed at studying drugs that might prevent dementia and other cognitive dysfunctions among HIV-positive people, a condition also known as "neuroAIDS," the AP/ABC News reports.

5 Oct 2006

Six shot course gives two year protection from hay fever

An experimental vaccine is promising to prevent hay fever symptoms for at least two years, and this is after just six injections.

5 Oct 2006

New clues about virulence of 1918 influenza virus

The first comprehensive analysis of an animal's immune response to the 1918 influenza virus provides new insights into the killer flu, report federally supported scientists in an article appearing online in the journal Nature.

28 Sep 2006

Protein linked to heart disease found to be more prevalent in low-income people, minorities and women

Low-income adults are more likely to have very high levels of C-reactive protein (CRP), a risk factor for heart disease, according to a study led by researchers at the University of Southern California.

21 Sep 2006

M. D. Anderson targets asthma and allergic diseases

A new research alliance focuses on a molecular master switch suspected of igniting the inflammatory immune response that drives asthma and other allergic diseases.

20 Sep 2006

Nicotinamide may help people with multiple sclerosis

Researchers have found a possible way to protect people with multiple sclerosis (MS) from severe long-term disability: increase nervous-system levels of a vital compound, called nicotinamide adenine dinucleotide (NAD), by giving its chemical precursor - nicotinamide, a form of vitamin B3.

19 Sep 2006

Researchers create roadmap to integrin activation

Calling it an important technical advance in the study of the complex receptors and pathways of the body's cellular system, researchers at the University of California, San Diego (UCSD) School of Medicine have reconstructed the signaling pathways that impact activation of a receptor that is critical to the control of bleeding and to the thrombosis that occurs in heart attacks and strokes.

18 Sep 2006

Treatments used for SARS no benefit to victims

Researchers have found, following a systematic review of all studies done on the 2003 SARS epidemic, that none of the treatments used to treat patients appear to have worked.

13 Sep 2006